Timber Hill’s GSK GSK Stock Holding History

Timber Hill’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,265	Closed	-$1.03M	–	688
2017 Q3	$1.13M	Buy	+22,265	New	+$1.13M	0.11%	170
2016 Q3	–	Sell	-6,752	Closed	-$370K	–	2080
2016 Q2	$366K	Buy	+6,752	New	+$356K	﹤0.01%	1720
2016 Q1	–	Sell	-54,204	Closed	-$2.7M	–	2174
2015 Q4	$2.73M	Buy	+54,204	New	+$2.76M	0.01%	817
2015 Q3	–	Sell	-34,413	Closed	-$1.79M	–	2479
2015 Q2	$1.79M	Buy	+34,413	New	+$1.94M	0.01%	1136
2015 Q1	–	Sell	-23,243	Closed	-$1.33M	–	2466
2014 Q4	$1.24M	Sell	23,243 -34,862	-60%	-$1.95M	0.01%	1304
2014 Q3	$3.34M	Buy	58,105 +47,945	+472%	+$2.94M	0.01%	821
2014 Q2	$679K	Buy	+10,160	New	+$688K	﹤0.01%	1901

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Timber Hill's GSK Position: Q4 2017 in Review

Timber Hill sold out of GSK (GSK) in Q4 2017, closing a stake of 22,265 shares — an estimated $1.03M sold.

Timber Hill first reported a position in GSK in Q2 2014 and held it in 7 quarters. The position peaked at $3.34M in Q3 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

Timber Hill reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
Timber Hill sold 22,265 GSK shares in Q4 2017, an estimated $1.03M.
Timber Hill first reported a position in GSK in Q2 2014 and held it in 7 quarters.
Timber Hill's GSK position peaked at $3.34M in Q3 2014.
763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Timber Hill's 13F filing for Q4 2017, filed 9 Feb 2018.